What are the challenges in the manufacturing of cancer treatments?
The manufacturing of cancer treatments faces several challenges:
- Complexity: The production of biologics and advanced therapies, such as CAR-T cells, involves complex and multi-step processes. - Regulatory Compliance: Manufacturers must adhere to stringent regulations set by entities like the FDA to ensure patient safety and drug efficacy. - Scalability: Scaling up production from lab-scale to commercial-scale while maintaining quality can be difficult. - Cost: High costs associated with specialized equipment, materials, and quality control measures can make cancer treatments expensive.
